Search - tctmd.com

Displaying 1 - 20 of 41

Sort: Relevancy | Date

Presentation TCT 2025

First Report of the SPYRAL AFFIRM Study: Reduced Home and Office Blood Pressure Following Radiofrequency Renal Denervation in a Large US Cohort of High Cardiovascular Risk Patients.

Presenter: Felix Mahfoud

October 27, 2025

Presentation TCT 2025

TCT 591: High Diastolic Blood Pressure as a Predictor of Limitation of Cerebroprotective Effects of Renal Denervation

Presenter: Alla Falkovskaya

October 27, 2025

Presentation TCT 2025

TCT 592: INTRAVASCULAR ULTRASOUND-GUIDED DRUG ELUTING STENTING FOR RENAL ARTERY STENOSIS: SINGLE CENTER PILOT STUDY 2017-2023

Presenter: Muhammad Haisum Maqsood

October 27, 2025

Presentation TCT 2025

TCT 1917: Challenging Case of Repeat Renal Denervation for Uncontrolled Hypertension

Presenter: Mina Madan

October 27, 2025

Presentation TCT 2025

TCT 590: Single-Center Real world use of the Paradise Renal Denervation Catheter. Early experience from the Cleveland Clinic.

Presenter: Anmol Multani

October 27, 2025

Presentation TCT 2025

TCT 588: 24-Month Durability of the Blood Pressure Lowering Effect of Ultrasound Renal Denervation for Hypertension with the Paradise System

Presenter: Ajay J. Kirtane

October 27, 2025

Presentation TCT 2025

Renal Denervation is FDA Approved - Will it Ever Be First Line Therapy?

Presenter: David P. Lee

October 27, 2025

Presentation TCT 2025

Where Do We See Renal Denervation in the Hypertension Pathway, Now and in Five Years?

Presenter: David E. Kandzari

October 27, 2025

Presentation TCT 2025

TCT 589: Same Day Discharge with the Symplicity Renal Denervation System: Outcomes from the Real World Global Symplicity Registry DEFINE

Presenter: Joachim Weil

October 27, 2025

Presentation TCT 2025

TCT 584: Renal Denervation for Resistant Hypertension in Fibromuscular Dysplasia: A Case Series

Presenter: Merlin Nikita

October 27, 2025

Presentation TCT 2025

TCT 583: Long-term Safety and Efficacy of Renal Sympathetic Denervation in Patients with Heart Failure with Reduced Ejection Fraction: 5-year results from the IMPROVE-HF-I study

Presenter: Kari A. Saville

October 27, 2025

Presentation TCT 2025

TCT 582: Ultrasound vs. Radiofrequency Renal Denervation: A Comparative Analysis

Presenter: Anmol Multani

October 27, 2025

Presentation TCT 2025

TCT 581: Renal Sympathetic Denervation as Adjunctive Upstream Therapy during Atrial Fibrillation Ablation: Pooled Analysis of the HFIB and Ultra-HFIB Studies

Presenter: Vivek Y. Reddy

October 27, 2025

Presentation TCT 2025

TCT 585: Renal Denervation Combined with Atrial Fibrillation Ablation in Heart Failure: Interim 6-Month Data on Reverse Remodeling and Arrhythmia Recurrence

Presenter: Tomasz Skowerski

October 27, 2025

Presentation TCT 2025

TCT 586: Diuretic Management in Patients Treated with Greater Splanchnic Nerve Ablation for HFpEF: REBALANCE-HF Randomized Trial

Presenter: Sheldon E. Litwin

October 27, 2025

Presentation TCT 2025

TCT 577: Efficacy and Safety of Ultrasound-Based Renal Denervation in Patients with Autosomal Dominant Polycystic Kidney Disease: Results from the RDN-ADPKD study

Presenter: Roland E. Schmieder

October 27, 2025

Presentation TCT 2025

TCT 578: Temporal Trends and Mortality Patterns of Hypertension and Metabolic Disorders in the U.S: A CDC-Based Study (1999–2020)

Presenter: Zoha Mujtaba

October 27, 2025

Presentation TCT 2025

TCT 580: Initial, Prospective Analysis of Uncontrolled Hypertensive Patients Included in the Global Paradise System (GPS) Registry Outside of the United States

Presenter: Karl Fengler

October 27, 2025

Presentation TCT 2025

Case 5: My 80YO Patient With Hypertension is Asking for Renal Denervation - Will They Benefit?

Presenter: Chandan Devireddy

October 27, 2025

Presentation TCT 2025

TCT 575: Long-term Safety and Efficacy of Renal Sympathetic Denervation: a Propensity-matched Approach

Presenter: Kari A. Saville

October 27, 2025

Advertisement

First Report of the SPYRAL AFFIRM Study: Reduced Home and Office Blood Pressure Following Radiofrequency Renal Denervation in a Large US Cohort of High Cardiovascular Risk Patients.

TCT 591: High Diastolic Blood Pressure as a Predictor of Limitation of Cerebroprotective Effects of Renal Denervation

TCT 592: INTRAVASCULAR ULTRASOUND-GUIDED DRUG ELUTING STENTING FOR RENAL ARTERY STENOSIS: SINGLE CENTER PILOT STUDY 2017-2023

TCT 1917: Challenging Case of Repeat Renal Denervation for Uncontrolled Hypertension

TCT 590: Single-Center Real world use of the Paradise Renal Denervation Catheter. Early experience from the Cleveland Clinic.

TCT 588: 24-Month Durability of the Blood Pressure Lowering Effect of Ultrasound Renal Denervation for Hypertension with the Paradise System

Renal Denervation is FDA Approved - Will it Ever Be First Line Therapy?

Where Do We See Renal Denervation in the Hypertension Pathway, Now and in Five Years?

TCT 589: Same Day Discharge with the Symplicity Renal Denervation System: Outcomes from the Real World Global Symplicity Registry DEFINE

TCT 584: Renal Denervation for Resistant Hypertension in Fibromuscular Dysplasia: A Case Series

TCT 583: Long-term Safety and Efficacy of Renal Sympathetic Denervation in Patients with Heart Failure with Reduced Ejection Fraction: 5-year results from the IMPROVE-HF-I study

TCT 582: Ultrasound vs. Radiofrequency Renal Denervation: A Comparative Analysis

TCT 581: Renal Sympathetic Denervation as Adjunctive Upstream Therapy during Atrial Fibrillation Ablation: Pooled Analysis of the HFIB and Ultra-HFIB Studies

TCT 585: Renal Denervation Combined with Atrial Fibrillation Ablation in Heart Failure: Interim 6-Month Data on Reverse Remodeling and Arrhythmia Recurrence

TCT 586: Diuretic Management in Patients Treated with Greater Splanchnic Nerve Ablation for HFpEF: REBALANCE-HF Randomized Trial

TCT 577: Efficacy and Safety of Ultrasound-Based Renal Denervation in Patients with Autosomal Dominant Polycystic Kidney Disease: Results from the RDN-ADPKD study

TCT 578: Temporal Trends and Mortality Patterns of Hypertension and Metabolic Disorders in the U.S: A CDC-Based Study (1999–2020)

TCT 580: Initial, Prospective Analysis of Uncontrolled Hypertensive Patients Included in the Global Paradise System (GPS) Registry Outside of the United States

Case 5: My 80YO Patient With Hypertension is Asking for Renal Denervation - Will They Benefit?

TCT 575: Long-term Safety and Efficacy of Renal Sympathetic Denervation: a Propensity-matched Approach

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content